April 2, 2018 / 12:49 PM / 5 months ago

BRIEF-Cerus’ Redes Phase 3 Red Blood Cell Study Expands Into The Continental U.S.

April 2 (Reuters) - Cerus Corp:

* ‘ REDES PHASE 3 RED BLOOD CELL STUDY EXPANDS INTO THE CONTINENTAL U.S.

* BAYLOR ST. LUKE’S MEDICAL CENTER IN HOUSTON BECAME FIRST CENTER IN CONTINENTAL U.S. TO ENROLL PATIENTS IN CO’S REDES STUDY

* EXPECT SEVERAL MORE SITES IN CONTINENTAL U.S. TO BEGIN ENROLLING PATIENTS FOR REDES STUDY IN COMING MONTHS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below